[{"Assets_0_Q2_USD":83965000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":4420000000.0,"NetIncomeLoss_1_Q2_USD":2670000000.0,"NetIncomeLoss_2_Q2_USD":5585000000.0,"StockholdersEquity_0_Q2_USD":27635000000.0,"EarningsPerShareBasic_2_Q2_USD":2.17,"EarningsPerShareBasic_1_Q2_USD":1.04,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":2574000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":2579000000.0,"Ticker":"MRK","CIK":"310158","name":"MERCK & CO., INC.","OfficialName":"Merck & Company Inc. Common Stock (new)","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"216907411162.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190806"}]